The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,024,113 in first-year total cost, median $715,222.
Most frequent study sections
- Special Emphasis Panel[ZRG1 MGG-M (70)]3
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
- UNIVERSITY OF FLORIDA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Robust verification of genetic variant-associated candidate off-target sites1U01AI191210-01 | BAUER, DANIEL EVANPELLIN, DANILOPINELLO, LUCA | BOSTON CHILDREN'S HOSPITAL, MA | $856,513 | ZRG1 |
| 2025 | Validated Immunoassays to Accelerate Therapeutic Genome Editing INDs1U01AI191209-01 | HARTIGAN-O'CONNOR, DENNIS J.TARANTAL, ALICE F | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $715,222 | ZRG1 |
| 2025 | Evaluation of High-throughput Extracellular Vesicle Loading Platform for Therapeutic Genome Editing INDs1U01AI191208-01 | HE, MEI | UNIVERSITY OF FLORIDA, FL | $452,378 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.